Literature DB >> 554435

[Synthesis of 7351, a new antimalarial drug (author's transl)].

X Y Zheng, Y Xia, F H Gao, C Chen.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 554435

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN： 0513-4870


× No keyword cloud information.
  11 in total

1.  Synergism between pyronaridine and retinol in Plasmodium vivax in vitro.

Authors:  Julia Riedl; Gunther Wernsdorfer; Kanungnit Congpuong; Ursula Wiedermann; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2010-10       Impact factor: 1.704

Review 2.  Combination therapy for malaria: the way forward?

Authors:  François Nosten; Philippe Brasseur
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Synergism between pyronaridine and retinol in Plasmodium falciparum in vitro.

Authors:  Pippa Proell; Kanungnit Congpuong; Franz F Reinthaler; Gunther Wernsdorfer; Ursula Wiedermann; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2009-10       Impact factor: 1.704

4.  Review of pyronaridine anti-malarial properties and product characteristics.

Authors:  Simon L Croft; Stephan Duparc; Sarah J Arbe-Barnes; J Carl Craft; Chang-Sik Shin; Lawrence Fleckenstein; Isabelle Borghini-Fuhrer; Han-Jong Rim
Journal:  Malar J       Date:  2012-08-09       Impact factor: 2.979

5.  Global gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine.

Authors:  Kanyanan Kritsiriwuthinan; Sastra Chaotheing; Philip J Shaw; Chayaphat Wongsombat; Porntip Chavalitshewinkoon-Petmitr; Sumalee Kamchonwongpaisan
Journal:  Malar J       Date:  2011-08-18       Impact factor: 2.979

6.  Environmentally Responsible and Cost-Effective Synthesis of the Antimalarial Drug Pyronaridine.

Authors:  Joseph R A Kincaid; Rahul D Kavthe; Juan C Caravez; Balaram S Takale; Ruchita R Thakore; Bruce H Lipshutz
Journal:  Org Lett       Date:  2022-05-03       Impact factor: 6.072

7.  Old drug repurposing for neglected disease: Pyronaridine as a promising candidate for the treatment of Echinococcus granulosus infections.

Authors:  Jun Li; Weisi Wang; Junmin Yao; Tian Wang; Shizhu Li; Wenjing Qi; Shuai Han; Yuan Ren; Zhisheng Dang; Xiumin Han; Gang Guo; Baoping Guo; Liqin Wang; Liping Duan; Wenbao Zhang
Journal:  EBioMedicine       Date:  2020-04-09       Impact factor: 8.143

Review 8.  Re-Envisioning Anti-Apicomplexan Parasite Drug Discovery Approaches.

Authors:  Gabriel W Rangel; Manuel Llinás
Journal:  Front Cell Infect Microbiol       Date:  2021-06-11       Impact factor: 5.293

9.  Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.

Authors:  Matthias Rottmann; Brian Jonat; Christin Gumpp; Satish K Dhingra; Marla J Giddins; Xiaoyan Yin; Lassina Badolo; Beatrice Greco; David A Fidock; Claude Oeuvray; Thomas Spangenberg
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

10.  Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.

Authors:  Thomas R Lane; Christopher Massey; Jason E Comer; Manu Anantpadma; Joel S Freundlich; Robert A Davey; Peter B Madrid; Sean Ekins
Journal:  PLoS Negl Trop Dis       Date:  2019-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.